The proposed acquisition and formation of a new organization, Risant Health, should not affect the two systems’ “AA-” ratings. The outlook should also remain stable for both systems.
Issues to address include the merger of two systems far apart in geography as well as the debt structure of the deal should it close, S&P added.
